Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115331 ↗At a glance
Leitlinie in European Journal of Cancer, 2025. Written by Damian T Rieke and 19 co-authors. Institution: Comprehensive Cancer Center and Department for Hematology, Oncology and Cancer Immunology Campus Benjamin Franklin, Charité - Universitätsmedizin Ber…. Major MEDLINE topics: Hematology, Medical Oncology, Neoplasms, Precision Medicine. Cited 7 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Precision oncology is a multi-step process including patient selection, tumor profiling, molecular tumor board discussion and personalized cancer management. So far, it remains largely unstandardized. The implementation of precision oncology can be beneficial for patients but implementation differs widely between tumor types and local practices. A working group was established by the Austrian, German and Swiss societies for Hematology and Medical Oncology to establish an expert consensus on evidence-based standards and implementation of precision oncology. Herein, we present a summary of this guideline. The full documents are available at www.onkopedia-guidelines.info.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Comprehensive Cancer Center and Department for Hematology, Oncology and Cancer Immunology Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Germany. Electronic address: damian.rieke@charite.de.
- Department of Internal Medicine I, University Hospital Tübingen, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Department of Medicine A, Hematology, Oncology and Pneumology, West German Cancer Center, University Hospital Muenster, Muenster, Germany.
- University Cancer Center Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
- Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, Dusseldorf, Germany.
Cite
APA
Rieke, D. T., Bitzer, M., Bleckmann, A., Desuki, A., Ernst, T., Esposito, I., Gerger, A., Glimm, H., Horak, P., Hübschmann, D., Illert, A. L., Kunzmann, V., Loges, S., Pretzell, I., Schmitz, K., Seeber, A., Söhlke, B., Wicki, A., Wolf, J., & Maschmeyer, G. (2025). Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115331
Vancouver
Rieke DT, Bitzer M, Bleckmann A, Desuki A, Ernst T, Esposito I, et al. Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115331
BibTeX
@article{Rieke2025,
author = {Rieke, Damian T and Bitzer, Michael and Bleckmann, Annalen and Desuki, Alexander and Ernst, Thomas and Esposito, Irene and Gerger, Armin and Glimm, Hanno and Horak, Peter and Hübschmann, Daniel and Illert, Anna Lena and Kunzmann, Volker and Loges, Sonja and Pretzell, Ina and Schmitz, Katja and Seeber, Andreas and Söhlke, Bärbel and Wicki, Andreas and Wolf, Jürgen and Maschmeyer, Georg},
title = {Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115331}
}
EUVIMED